A Recombinant Bispecific CD20×CD95 Antibody With Superior Activity Against Normal and Malignant B-cells

Monoclonal antibodies directed to the B-cell-specific CD20-antigen are successfully used for the treatment of lymphomas and autoimmune diseases. Here, we compare the anti-B-cell activity of three different antibodies directed to CD20: (i) a chimeric, monospecific antibody, (ii) an Fc-optimized varia...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther
Main Authors: Nalivaiko, Kristina, Hofmann, Martin, Kober, Karina, Teichweyde, Nadine, Krammer, Peter H, Rammensee, Hans-Georg, Grosse-Hovest, Ludger, Jung, Gundram
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4817817/
https://ncbi.nlm.nih.gov/pubmed/26581163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2015.209
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados